Adrenal suppression following intralesional corticosteroids for periocular haemangiomas

Morkane, Clare, Gregory, John Welbourn ORCID: https://orcid.org/0000-0001-5189-3812, Watts, Patrick and Warner, Justin T. 2011. Adrenal suppression following intralesional corticosteroids for periocular haemangiomas. Archives of Disease in Childhood 96 (6) , pp. 587-589. 10.1136/adc.2010.204859

Preview

PDF Download (386kB) | Preview

Abstract

Background/aims Treatment with intralesional triamcinolone/betamethasone is recommended for infantile sight-threatening periocular haemangiomas. This study investigates the endocrine and weight changes in 15 infants undergoing therapy over 12 years. Methods 15 infants, median age 19 weeks (range 10–56) receiving intra/perilesional triamcinolone/betamethasone underwent serial measurement of weight, early morning serum cortisol and adrenocorticotropic hormone (ACTH) before and after injection. Results Cortisol fell from a median (range) of 383 (112–594) to 28 (<10–506) nmol/l (p=0.005) and ACTH from 26 (14–134) to 9 (5–20) ng/l (p=0.05) from before injection to 4 weeks after treatment. Prolonged adrenal suppression occurred in 13 out of 15 cases with time to recovery being 19.5 (4–65) weeks. Failure to gain weight appropriately was observed in 14 infants but recovered once normal adrenal function was re-established. Conclusion Prolonged adrenal suppression following triamcinolone/betamethasone injection for periocular haemangiomas is common and associated with faltering weight gain.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RJ Pediatrics
Publisher:	BMJ Publishing Group
ISSN:	0003-9888
Last Modified:	08 May 2023 03:11
URI:	https://orca.cardiff.ac.uk/id/eprint/16367

Citation Data

Cited 18 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item